Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Is This Dividend Growth Stock a Buy?

TheMotleyFool

0 0

Is This Dividend Growth Stock a Buy?: https://g.foolcdn.com/editorial/images/711880/surgeons-perform-a-surgery-in-the-operating-room.jpg

Economic concerns ranging from elevated inflation to interest rate hikes have heavily weighed on financial markets this year. This explains why the S&P 500 index has dropped over 17% so far in 2022.

But many stocks have outperformed the index during this time, especially in healthcare. Down just 11% to this point in the year, Stryker (NYSE: SYK) fits into this category. This raises the following two questions: Can the stock's market-beating performance continue? And is Stryker a buy?

Let's dive into the company's fundamentals and valuation to get answers to these questions.

Source Fool.com

Like: 0

SYK

Share